subgroup of
drug)
→
ReceivesAction
→
described in section 505(a
| Typicality: | 0.537 |
| Saliency: | 0.671 |
| of the act | 45 | other |
| new drug → be described in → section 505(a | 46 |
| negative | neutral | positive |
| 0.445 | 0.535 | 0.020 |
| Raw frequency | 46 |
| Normalized frequency | 0.671 |
| Modifier score | 0.500 |
| Perplexity | 329.785 |